Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000004

GENERAL COUNSEL & CORP SEC acquired 25,475 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-15 Option exercise +7,475 19,731 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-15 Option exercise +6,000 25,731 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-15 Option exercise +12,000 37,731 D
Derivatives
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-15 Option exercise · Restricted Stock Units −7,475 7,475 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-15 Option exercise · Restricted Stock Units −6,000 12,000 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-15 Option exercise · Restricted Stock Units −12,000 36,000 D
Loading xslF345X05/form4-03172026_090341.xml…